Pharma IQ Members


Contamination is defined as the undesired introduction of impurities of a chemical or microbiological nature, or of foreign matter, into or onto a raw material, intermediate, or API (Active Pharmaceutical Ingredient) during production, sampling, packaging or repackaging, storage or transport.

62.5% of Biologics Professionals Have Strategy in Place to Mitigate Risks of Contamination

Within the next five years, the global biologics market is set to exceed $239 billion (£145 billion) in value, according to recent research by Bharat Book. As innovation brings down production costs and more comprehensive pipelines emerge, there...

Contributor: Pharma IQ
Tue, 09/06/2011
Andrea Charles

Dr. Barbara J. Potts, Senior Consultant, Potts and Nelson Consulting, joins Andrea Charles from Pharma, IQ to discuss the biggest threats to the safety of biologics and which contaminants present the most problems. Potts also shares her insights...

Contributor: Andrea Charles
Wed, 08/17/2011
Pharma IQ

By 2015, the global market for biologics is expected to reach $239 billion (£147 billion), thanks to more comprehensive drugs pipelines, development of biosimilars and innovations to slash production costs, according to research by Bharat Book....

Contributor: Pharma IQ
Tue, 07/26/2011